[1]
|
Giannoula, E., Melidis, C., Papadopoulos, N., Bamidis, P., Raftopoulos, V. and Iakovou, I. (2020) Dynamic Risk Stratification for Predicting Treatment Response in Differentiated Thyroid Cancer. Journal of Clinical Medicine, 9, Article No. 2708. https://doi.org/10.3390/jcm9092708
|
[2]
|
Donegan, D., McIver, B. and Algeciras-Schimnich, A. (2014) Clinical Consequences of a Change in Anti-Thyroglobulin Antibody Assays during the Follow-Up of Patients with Differentiated Thyroid Cancer. Endocrine Practice, 20, 1032-1036. https://doi.org/10.4158/EP13499.OR
|
[3]
|
Jo, K. and Lim, D.J. (2018) Clinical Implications of Anti-Thyroglobulin Antibody Measurement before Surgery in Thyroid Cancer. Korean Journal of Internal Medicine, 33, 1050-1057. https://doi.org/10.3904/kjim.2018.289
|
[4]
|
Jeong, J.S., Kim, H.K., Lee, C.R., Park, S., Park, J.H., Kang, S.W., Jeong, J.J., Nam, K.H., Chung, W.Y. and Park, C.S. (2012) Coexistence of Chronic Lymphocytic Thyroiditis with Papillary Thyroid Carcinoma: Clinical Manifestation and Prognostic Outcome. Journal of Korean Medical Sciences, 27, 883-889. https://doi.org/10.3346/jkms.2012.27.8.883
|
[5]
|
Duval, M.A.D.S., Zanella, A.B., Cristo, A.P., Faccin, C.S., Graudenz, M.S., Maia, A.L. (2017) Impact of Serum TSH and Anti-Thyroglobulin Antibody Levels on Lymph Node Fine-Needle Aspiration Thyroglobulin Measurements in Differentiated Thyroid Cancer Patients. European Thyroid Journal, 6, 292-297. https://doi.org/10.1159/000479682
|
[6]
|
Haugen, B.R., Alexander, E.K., Bible, K.C., Doherty, G.M., Mandel, S.J., Nikiforov, Y.E., Pacini, F., Randolph, G.W., Sawka, A.M., Schlumberger, M., Schuff, K.G., Sherman, S.I., Sosa, J.A., Steward, D.L., Tuttle, R.M. and Wartofsky, L. (2016) American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26, 1-133. https://doi.org/10.1089/thy.2015.0020
|
[7]
|
Spencer, C.A. (2011) Clinical Review: Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC). Journal of Clinical Endocrinology and Metabolism, 96, 3615-3627. https://doi.org/10.1210/jc.2011-1740
|
[8]
|
Chiovato, L., Latrofa, F., Braverman, L.E., Pacini, F., Capezzon, M., Masserini, L., Grasso, L. and Pinchera, A. (2003) Disappearance of Humoral Thyroid Autoimmunity after Complete Removal of Thyroid Antigens. Annals of Internal Medicine, 139, 346-351. https://doi.org/10.7326/0003-4819-139-5_Part_1-200309020-00010
|
[9]
|
Locsei, Z., Szabolcs, I., Rácz, K., Kovács, G.L., Horváth, D. and Toldy, E. (2012) Serum Thyroglobulin Antibody Levels within or Near to the Reference Range May Interfere with Thyroglobulin Measurement. Biochemical Medicine, 22, 365-370. https://doi.org/10.11613/BM.2012.038
|
[10]
|
Algeciras-Schimnich, A. (2018) Thyroglobulin Measurement in the Management of Patients with Differentiated Thyroid Cancer. Critical Reviews in Clinical Laboratory Sciences, 55, 205-218. https://doi.org/10.1080/10408363.2018.1450830
|
[11]
|
Durante, C., Tognini, S., Montesano, T., Orlandi, F., Torlontano, M., Puxeddu, E., Attard, M., Costante, G., Tumino, S., Meringolo, D., Bruno, R., Trulli, F., Toteda, M., Redler, A., Ronga, G., Filetti, S. and Monzani, F. (2014) Clinical Aggressiveness and Long-Term Outcome in Patients with Papillary Thyroid Cancer and Circulating Anti-Thyroglobulin Autoantibodies. Thyroid, 24, 1139-1145. https://doi.org/10.1089/thy.2013.0698
|
[12]
|
Chung, J.-K., Park, Y.J., Kim, T.Y., So, Y., Kim, S.K., Park, D.J., Lee, D.S., Lee, M.C. and Cho, B.Y. (2002) Clinical Significance of Elevated Level Of Serum Antithyroglobulin Antibody in Patients with Differentiated Thyroid Cancer after Thyroid Ablation. Clinical Endocrinology, 57, 215-221. https://doi.org/10.1046/j.1365-2265.2002.01592.x
|
[13]
|
Kim, W.G., Yoon, J.H., Kim, W.B., Kim, T.Y., Kim, E.Y., Kim, J.M., Ryu, J.S., Gong, G., Hong, S.J. and Shong, Y.K. (2008) Change of Serum Antithyroglobulin Antibody Levels Is Useful for Prediction of Clinical Recurrence in Thyroglobulin-Negative Patients with Differentiated Thyroid Carcinoma. Journal of Clinical Endocrinology and Metabolism, 93, 4683-4689. https://doi.org/10.1210/jc.2008-0962
|
[14]
|
Hsieh, C.J. and Wang, P.W. (2014) Sequential Changes of Serum Antithyroglobulin Antibody Levels Are a Good Predictor of Disease Activity in Thyroglobulin-Negative Patients with Papillary Thyroid Carcinoma. Thyroid, 24, 488-493. https://doi.org/10.1089/thy.2012.0611
|
[15]
|
Tsushima, Y., Miyauchi, A., Ito, Y., Kudo, T., Masuoka, H., Yabuta, T., Fukushima, M., Kihara, M., Higashiyama, T., Takamura, Y., Miya, A., Kobayashi, K., Kikumori, T., Imai, T. and Kiuchi, T. (2013) Prognostic Significance of Changes in Serum Thyroglobulin Antibody Levels of Pre- and Post-Total Thyroidectomy in Thyroglobulin Antibody-Positive Papillary Thyroid Carcinoma Patients. Endocrinology Journal, 60, 871-876. https://doi.org/10.1507/endocrj.EJ12-0410
|
[16]
|
Verburg, F.A., Luster, M., Cupini, C., Chiovato, L., Duntas, L., Elisei, R., Feldt-Rasmussen, U., Rimmele, H., Seregni, E., Smit, J.W., Theimer, C. and Giovanella, L. (2013) Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement. Thyroid, 23, 1211-1225. https://doi.org/10.1089/thy.2012.0606
|
[17]
|
Soyluk, O., Boztepe, H., Aral, F., Alagol, F. and Özbey, N.C. (2011) Papillary Thyroid Carcinoma Patients Assessed to Be at Low or Intermediary Risk after Primary Treatment Are at Greater Risk of Long Term Recurrence If They Are Thyroglobulin Antibody Positive or Do Not Have Distinctly Low Thyroglobulin at Initial Assessment. Thyroid, 21, 1301-1308. https://doi.org/10.1089/thy.2011.0122
|
[18]
|
Jia, X., Pang, P., Wang, L., Zhao, L., Jiang, L., Song, Y., Fan, X., Wang, Y., Zhao, S., Ba, J., Yang, G., Wang, X., Gu, W., Zang, L., Pei, Y., Du, J., Mu, Y. and Lyu, Z. (2020) Clinical Analysis of Preoperative Anti-Thyroglobulin Antibody in Papillary Thyroid Cancer between 2011 and 2015 in Beijing, China: A Retrospective Study. Frontiers in Endocrinology, 15, Article 452. https://doi.org/10.3389/fendo.2020.00452
|
[19]
|
Morbelli, S., Ferrarazzo, G., Pomposelli, E., Pupo, F., Pesce, G., Calamia, I., Fiz, F., Clapasson, A., Bauckneht, M., Minuto, M., Sambuceti, G., Giusti, M. and Bagnasco, M. (2017) Relationship between Circulating Anti-Thyroglobulin Antibodies (TgAb) and Tumor Metabolism in Patients with Differentiated Thyroid Cancer (DTC): Prognostic Implications. Journal of Endocrinological Investigation, 40, 417-424. https://doi.org/10.1007/s40618-016-0578-6
|
[20]
|
Qin, J., Yu, Z., Guan, H., Shi, L., Liu, Y., Zhao, N., Shan, Z., Han, C., Li, Y. and Teng, W. (2015) High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma. Disease Markers, 2015, Article ID: 648670. https://doi.org/10.1155/2015/648670
|
[21]
|
Sun, D., Zheng, X., He, X., Huang, C., Jia, Q., Tan, J., Zheng, W., Li, N., Wang, P., Wang, R., Liu, M., Zhao, L., Yuan, S., Meng, Z. and Fan, Y. (2020) Prognostic Value and Dynamics of Antithyroglobulin Antibodies for Differentiated Thyroid Carcinoma. Biomarker Medicine, 14, 1683-1692. https://doi.org/10.2217/bmm-2019-0432
|
[22]
|
Trimboli, P., Zilioli, V., Imperiali, M. and Giovanella, L. (2017) Thyroglobulin Autoantibodies before Radioiodine Ablation Predict Differentiated Thyroid Cancer Outcome. Clinical Chemistry and Laboratory Medicine, 55, 1995-2001. https://doi.org/10.1515/cclm-2017-0033
|
[23]
|
Zavala, L.F., Barra, M.I., Olmos, R., Tuttle, M., González, H., Droppelmann, N., Mosso, L. and Domínguez, J.M. (2019) In Properly Selected Patients with Differentiated Thyroid Cancer, Antithyroglobulin Antibodies Decline after Thyroidectomy and Their Sole Presence Should Not Be an Indication for Radioiodine Ablation. Archives of Endocrinology Metabolism, 63, 293-299. https://doi.org/10.20945/2359-3997000000123
|
[24]
|
Scappaticcio, L., Trimboli, P., Verburg, F.A. and Giovanella L. (2020) Significance of “de novo” Appearance of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer. International Journal of Biological Markers, 35, 41-49. https://doi.org/10.1177/1724600820931517
|
[25]
|
McLeod, D.S., Cooper, D.S., Ladenson, P.W., Ain, K.B., Brierley, J.D., Fein, H.G., Haugen, B.R., Jonklaas, J., Magner, J., Ross, D.S., Skarulis, M.C., Steward, D.L., Maxon, H.R. and Sherman, S.I. (2014) Prognosis of Differentiated Thyroid Cancer in Relation to Serum Thyrotropin and Thyroglobulin Antibody Status at Time of Diagnosis. Thyroid, 24, 35-42. https://doi.org/10.1089/thy.2013.0062
|
[26]
|
Rago, T., Di Coscio, G., Ugolini, C., Scutari, M., Basolo, F., Latrofa, F., Romani, R., Berti, P., Grasso, L., Braverman, L.E., Pinchera, A. and Vitti, P. (2007) Clinical Features of Thyroid Autoimmunity Are Associated with Thyroiditis on Histology and Are Not Predictive of Malignancy in 570 Patients with Indeterminate Nodules on Cytology Who Had a Thyroidectomy. Clinical Endocrinology, 67, 363-369. https://doi.org/10.1111/j.1365-2265.2007.02892.x
|
[27]
|
He, L.Z., Zeng, T.S., Pu, L., Pan, S.X., Xia, W.F. and Chen, L.L. (2016) Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer. International Journal of Endocrinology, 2016, Article ID: 8215834. https://doi.org/10.1155/2016/8215834
|
[28]
|
Hosseini, S., Payne, R.J., Zawawi, F., Mlynarek, A., Hier, M.P., Tamilia, M. and Forest, V.I. (2016) Can Preoperative Thyroglobulin Antibody Levels Be Used as a Marker for Well Differentiated Thyroid Cancer? Journal of Otolaryngology Head Neck Surgery, 45, Article No. 31. https://doi.org/10.1186/s40463-016-0143-5
|
[29]
|
Grani, G., Calvanese, A., Carbotta, G., D’Alessandri, M., Nesca, A., Bianchini, M., Del Sordo, M., Vitale, M. and Fumarola, A. (2015) Thyroid Autoimmunity and Risk of Malignancy in Thyroid Nodules Submitted to Fine-Needle Aspiration Cytology. Head Neck, 37, 260-264. https://doi.org/10.1002/hed.23587
|
[30]
|
Gholve, C., Kumarasamy, J., Damle, A., Kulkarni, S., Venkatesh, M., Banerjee, S. and Rajan, M.G.R. (2019) Comparison of Serum Thyroglobulin Levels in Differentiated Thyroid Cancer Patients Using In-House Developed Radioimmunoassay and Immunoradiometric Procedures. Indian Journal of Clinical Biochemistry, 34, 465-471. https://doi.org/10.1007/s12291-018-0768-4
|
[31]
|
Vasileiadis, I., Boutzios, G., Charitoudis, G., Koukoulioti, E. and Karatzas, T. (2014) Thyroglobulin Antibodies Could Be a Potential Predictive Marker for Papillary Thyroid Carcinoma. Annals of Surgical Oncology, 21, 2725-2732. https://doi.org/10.1245/s10434-014-3593-x
|
[32]
|
McGrath, R.T., Preda, V.A., Clifton-Bligh, P., Robinson, B., Sywak, M., Delbridge, L., Ward, P., Clifton-Bligh, R.J. and Learoyd, D.L. (2016) Is There a Role for an Ultrasensitive Thyroglobulin Assay in Patients with Serum Antithyroglobulin Antibodies? A Large (Australian) Cohort Study in Differentiated Thyroid Cancer. Clinical Endocrinology, 84, 271-277. https://doi.org/10.1111/cen.12736
|
[33]
|
Gorges, R., Maniecki, M., Jentzen, W., Sheu, S.N., Mann, K., Bockisch, A. and Janssen, O.E. (2015) Development and Clinical Impact of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Carcinoma during the First 3 Years after Thyroidectomy. European Journal of Endocrinology, 153, 49-55. https://doi.org/10.1530/eje.1.01940
|
[34]
|
Wassner, A.J., Della Vecchia, M., Jarolim, P., Feldman, H.A. and Huang, S.A. (2017) Prevalence and Significance of Thyroglobulin Antibodies in Pediatric Thyroid Cancer. Journal of Clinical Endocrinology & Metabolism, 102, 3146-3153. https://doi.org/10.1210/jc.2017-00286
|
[35]
|
Zhang, X., Zhang, X., Chang, Z., Wu, C. and Guo, H. (2018) Correlation Analyses of Thyroid-Stimulating Hormone and Thyroid Autoantibodies with Differentiated Thyroid Cancer. Journal of BUON, 23, 1467-1471.
|
[36]
|
Matrone, A., Latrofa, F., Torregrossa, L, Piaggi, P., Gambale, C., Faranda, A., Ricci, D., Agate, L., Molinaro, E., Basolo, F., Vitti, P. and Elisei, R. (2018) Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without 131I Ablation. Thyroid, 28, 871-879. https://doi.org/10.1089/thy.2018.0080
|
[37]
|
Jo, K., Kim, M.H., Ha, J., Lim, Y, Lee, S., Bae, J.S., Jung, C.K., Kang, M.I., Cha, B.Y. and Lim, D.J. (2017) Prognostic Value of Preoperative Anti-Thyroglobulin Antibody in Differentiated Thyroid Cancer. Clinical Endocrinology, 87, 292-299. https://doi.org/10.1111/cen.13367
|
[38]
|
Ora, M., Nazar, A.H., Mishra, P., Barai, S., Arya, A., Pradhan, P.K. and Gambhir, S. (2021) Clinical Outcome of Patients with Differentiated Thyroid Cancer and Raised Antithyroglobulin Antibody Levels: A Retrospective Study. Thyroid Research, 14, Article No. 8. https://doi.org/10.1186/s13044-021-00099-w
|
[39]
|
Seo, J.H., Lee, S.W., Ahn, B.C. and Lee, J. (2010) Recurrence Detection in Differentiated Thyroid Cancer Patients with Elevated Serum Level of Antithyroglobulin Antibody: Special Emphasis on Using 18F-FDG PET/CT. Clinical Endocrinology, 72, 558-563. https://doi.org/10.1111/j.1365-2265.2009.03693.x
|
[40]
|
Patell, R., Mikhael, A., Tabet, M., Bena, J., Berber, E. and Nasr, C. (2018) Assessing the Utility of Preoperative Serum Thyroglobulin in Differentiated Thyroid Cancer: A Retrospective Cohort Study. Endocrine, 61, 506-510. https://doi.org/10.1007/s12020-018-1643-z
|